Under this agreement, Intellection will expand its range of products and services, directly supplying XRF (X-ray fluorescence) and XRD (X-ray diffraction) systems from Bruker to its customers. This will reportedly allow both companies to develop highly competitive global sales strategies.
Calvin Treacy, Intellection’s CEO, said: “Intellection’s own technological credentials are impeccable, with our Qemscan solutions the international market leader across the resources sector. Bruker’s XRD and XRF technologies complement Qemscan analysis, making them an excellent business fit for us.”